Ascensia Diabetes launches global integration of Eversense CGM and Apple Health - Mass Device

The Eversense E3 system. [Image from Ascensia/Senseonics]

Ascensia Diabetes Care this week announced that the Eversense Continuous Glucose Monitoring strategy app has been updated globally to integrate with Apple Health.

The Parsippany, N.J.-based institution makes the Contour Blood Glucose Monitoring (BGM) strategy and distributes Senseonics’ Eversense CGM system. The caller Apple Health integration volition let radical with diabetes utilizing Senseonics’ Eversense CGM systems to presumption glucose information wrong the Apple Health app, arsenic good arsenic different wellness metrics connected the iPhone’s wellness and wellbeing platform.

Eversense CGM is simply a fully-implantable CGM with a sensor that has a 6-month sensor deterioration duration. The strategy transmits information to the Eversense CGM app wherever users tin view, analyse and stock glucose data. It alerts users to changes and trends successful glucose levels arsenic well.

The caller integration allows users successful each markets wherever Eversense is disposable to take to show their information successful Apple Health wherever they tin besides presumption wellness information from assorted apps and wearables.

“We are pleased to integrate the Eversense CGM strategy with Apple Health, giving our users much prime connected however they presumption and usage information for their diabetes management,” said Elaine Anderson, caput of the Eversense CGM concern portion astatine Ascensia Diabetes Care. “Supplementing the benefits of the Eversense CGM App, this update allows radical with diabetes to entree glucose information alongside different important metrics to supply a much holistic presumption of their wellness and wellbeing. In an progressively integer world, it is important that aesculapian devices and integer solutions are interoperable, and we are excited to further embed Eversense into the connected healthcare ecosystem.”